The ACS January 2018 Special Biochemistry Issue has included College of Chemistry professors Ming Hammond, Evan Miller, and David Savage among the 44 early career scientists identified as representing the future of biochemistry. These scientists are noted by the publication for tackling problems of biological relevance.
Kevan Shokat photographed at UCSF. Photo by Noah Berger.
The UC San Francisco scientist who developed a successful approach to drugging a protein produced by the mutated KRAS gene has won two prestigious awards in the opening weeks of 2023. The discovery, made by...
It was announced today thatVicinitas Therapeutics, a biotechnology company advancing a proprietary targeted protein stabilization platform to develop novel...
Joint press release; UC Berkeley and Novartis Institutes for BioMedical Research
Illustration of DUBTAC in action against a target. (Courtesy Nomura Lab)
Novartis-Berkeley Translational Chemical Biology Institute combines Novartis expertise in chemical biology and medicinal chemistry with Berkeley’s expertise in covalent chemoproteomics and chemistry methodologies Research collaboration aims to unlock...
Scientists have found that cancers in the pancreas (left) readily metastasize because these tumors suppress levels of an enzyme, MSRA, that pulls oxygen atoms off amino acids called methionine. As MSRA levels decrease, methionines on...
Becky Bish | The Mark Foundation for Cancer Research
Nomura in his lab at UC Berkeley. Photo: Elena Zhukova
Throughout the grim reality of a global pandemic that has disrupted normal life for months, one persistent bright spot has been the robust response of the biomedical research community. The battle to develop vaccines and drugs to fight the SARS-CoV-2 virus and COVID-19, the disease which it causes,...
A colored scanning electron micrograph of a cell of a common type of lung cancer, called non-small cell cancer. A new drug targets the mutated protein that leads to uncontrolled growth. Credit Steve Gschmeissner/Science Source
After 40 years of effort, researchers have finally succeeded in switching off...
The DNA-cutting proteins central to CRISPR-Cas9 and related gene-editing tools originally came from bacteria, but a newfound variety of Cas proteins apparently evolved in viruses that infect bacteria. The new Cas proteins were found in the largest known bacteria-infecting viruses, called bacteriophages, and are the most compact working Cas variants yet discovered — half the size of today’s workhorse, Cas9.